Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RIVASAN CAP 1.5MG - PPB Drug Approval Details

Approvals/PPB/RIVASAN CAP 1.5MG

Approved

STANDARD

RIVASAN CAP 1.5MG

SANDOZ HONG KONG LIMITED🇰🇪 Pharmacy and Poisons Board

Approval Date: Jun 21, 2024
Approval ID: ef44eccee7aee4f0
Company: SANDOZ HONG KONG LIMITED
Type: Standard

Approval Details

Approval Id: ef44eccee7aee4f0
Product Name: RIVASAN CAP 1.5MG
Drug Hk Name: RIVASAN CAP 1.5MG
Registration Code: HK-60940
Company Name: SANDOZ HONG KONG LIMITED
Company Detail Path: /organization/sandoz-hong-kong-limited
Registration Category: Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement: Prescription only Medicines
Registration Date: 2012-03-13
Company Address: UNIT 2901, NO. 28 STANLEY STREET, CENTRAL, HONG KONG

Active Ingredients

Approved

Quick Info

Agency

PPB

Country

🇰🇪

Approval Date

Jun 21, 2024

Approval ID

ef44eccee7aee4f0

Type

Standard

Back to PPB Approvals